Diether Manfreda

Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial

R. Greil, J. Bergh, F. Kainberger, 2015, The Lancet.

Duration of Adjuvant Aromatase-Inhibitor Therapy in Postmenopausal Breast Cancer.

R. Greil, M. Gnant, R. Jakesz, 2021, The New England journal of medicine.